BioSyent Inc.
BIOYF
$8.50
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.94% | 13.33% | 12.80% | 9.17% | 11.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.94% | 13.33% | 12.80% | 9.17% | 11.08% |
| Cost of Revenue | 30.23% | 22.15% | 23.62% | 17.93% | 23.59% |
| Gross Profit | 16.02% | 11.10% | 10.16% | 7.12% | 8.24% |
| SG&A Expenses | 34.40% | 31.85% | 33.17% | 28.84% | 6.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.36% | 35.48% | 37.09% | 32.69% | 10.96% |
| Operating Income | 57.56% | 47.74% | 43.17% | 46.71% | 11.44% |
| Income Before Tax | 22.33% | 13.86% | 9.04% | 12.87% | 11.58% |
| Income Tax Expenses | 35.27% | 19.63% | 14.47% | 19.21% | 6.37% |
| Earnings from Continuing Operations | 18.18% | 11.99% | 7.27% | 10.83% | 13.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.18% | 11.99% | 7.27% | 10.83% | 13.36% |
| EBIT | 57.56% | 47.74% | 43.17% | 46.71% | 11.44% |
| EBITDA | 61.43% | 50.80% | 46.86% | 50.02% | 10.62% |
| EPS Basic | 21.76% | 15.25% | 10.58% | 14.09% | 16.74% |
| Normalized Basic EPS | 54.19% | 45.15% | 40.92% | 47.62% | 14.90% |
| EPS Diluted | 21.54% | 14.96% | 10.28% | 14.04% | 16.76% |
| Normalized Diluted EPS | 53.82% | 44.70% | 40.59% | 47.51% | 14.92% |
| Average Basic Shares Outstanding | -2.93% | -2.76% | -3.01% | -3.05% | -3.05% |
| Average Diluted Shares Outstanding | -2.66% | -2.48% | -2.84% | -3.05% | -3.12% |
| Dividend Per Share | 8.24% | 8.37% | 8.50% | 10.79% | 8.42% |
| Payout Ratio | -0.11% | -0.06% | -0.02% | -0.03% | -0.07% |